Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca De Santis
Observed names:
F De Santis,
F. De Santis,
Francesca de Santis
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
Institució Catalana de Recerca i Estudis Avançats,
Universitat Pompeu Fabra,
University of Milan,
Cornell University,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
IFOM,
Fondazione IRCCS Istituto Nazionale dei Tumori,
European Institute of Oncology
show all 8
ORCID:
0000-0001-5877-0639
Observed ORCID:
0000-0001-5877-0639
OpenAlex ID:
A5030663884
The methyl-CpG binding protein MBD1 is required for PML-RARα function
2006
·
Raffaella Villa
, Lluis Morey
, et al.
·
Proceedings of the National Academy of Sciences
·
118
Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells
2014
·
Federico Colombo
, Elena Trombetta
, et al.
·
PLoS ONE
·
51
PDF
Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability
2011
·
Giorgio Iotti
, Elena Longobardi
, et al.
·
Proceedings of the National Academy of Sciences
·
45
Epigenetic gene silencing in acute promyelocytic leukemia
2004
·
R Villa
, F De Santis
, et al.
·
Biochemical Pharmacology
·
38
Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure
2020
·
Lorenzo Castagnoli
, Francesca De Santis
, et al.
·
Cells
·
34
PDF
Stabilization of c-KIT G-Quadruplex DNA Structures by the RNA Polymerase I Inhibitors BMH-21 and BA-41
2019
·
Stefania Mazzini
, Raimundo Gargallo
, et al.
·
International Journal of Molecular Sciences
·
32
PDF
Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy
2016
·
Francesca D’Avila
, Mirella Meregalli
, et al.
·
Journal of Muscle Research and Cell Motility
·
31
PDF
Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I
2017
·
Paola Frattini
, Chiara Villa
, et al.
·
Human Molecular Genetics
·
29
PDF
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer
2022
·
Francesca De Santis
, Sandra L. Romero-Cordoba
, et al.
·
Cellular Oncology
·
22
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade
2024
·
Licia Rivoltini
, Chiara Camisaschi
, et al.
·
Scientific Reports
·
16
PDF
Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer
2021
·
Francesco Mainini
, Francesca De Santis
, et al.
·
Cancers
·
13
PDF
A combination of extracellular matrix‐ and interferon‐associated signatures identifies high‐grade breast cancers with poor prognosis
2021
·
Mara Lecchi
, Paolo Verderio
, et al.
·
Molecular Oncology
·
9
PDF
Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer
2016
·
Elisa Dama
, Micol Tillhon
, et al.
·
Oncotarget
·
9
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells
2021
·
Giovanni Fucà
, Margherita Ambrosini
, et al.
·
Journal for ImmunoTherapy of Cancer
·
8
PDF
Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?
2021
·
Margherita Ambrosini
, Giovanni Fucà
, et al.
·
Critical Reviews in Oncology/Hematology
·
6
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition
2021
·
Francesca De Santis
, Giovanni Fucà
, et al.
·
Cytokine & Growth Factor Reviews
·
6
PDF
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting
2018
·
F. De Santis
, M. Del Vecchio
, et al.
·
Cytokine & Growth Factor Reviews
·
2
CAR-engineering of innate and innate-like immune cells: a new horizon in adoptive cell therapy for solid tumors
2026
·
Giuseppe Nardo
, Francesca Putti
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
43P Immunosuppressive microenvironment can be reverted by neoadjuvant chemotherapy in TNBC
2025
·
F. De Santis
, M. Lecchi
, et al.
·
ESMO Open
·
1
PDF
GLOBO H targeting CAR T Cells: generation and preclinical activity in gastrointestinal cancer cell lines
2026
·
Francesca Putti
, Marco Gentili
, et al.
·
Journal of Experimental & Clinical Cancer Research
73P Enhancing CAR T cell therapy through the epigenetic reprogramming of memory gene transcriptional circuits
2026
·
F. De Santis
, C. Fornasier
, et al.
·
ESMO Open
PDF
Abstract A020: Reversing triple negative breast cancer stem cells by disrupting the Notch signaling pathway via BCL6 targeting
2023
·
Francesca De Santis
, Francesca Putti
, et al.
·
Molecular Cancer Therapeutics
17P BCL6 and Notch pathway: A signaling axis leading to a novel druggable biotarget in triple-negative breast cancer
2021
·
F. De Santis
, S.L. Romero-Cordoba
, et al.
·
Annals of Oncology
Author response for "A combination of extracellular matrix‐ and interferon‐associated signatures identifies high‐grade breast cancers with poor prognosis"
2020
·
Mara Lecchi
, Paolo Verderio
, et al.
·
Publons reviews and discussion
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy
2020
·
Matteo Bellone
, Arianna Brevi
, et al.
·
Cancer Immunology Immunotherapy
Show more works
View as search
Works count:
28
Citation count:
471
H-index:
11
I10-index:
11
Year
Topic
Type